Why Some People Gain Weight on Wegovy — and What to Do About It

Step 1, Recognise that a plateau is not the same as gain

The first thing worth separating out is the difference between slowed loss and actual weight gain. Wegovy's titration schedule (starting at 0.25 mg and stepping up through 0.5 mg, 1.0 mg and 1.7 mg to the 2.4 mg maintenance dose) means appetite suppression increases gradually. During the earlier steps, some people find their weight barely moves, or nudges up slightly before the medicine reaches its full effect. That temporary plateau is not the same as the treatment failing.

True weight gain during active Wegovy treatment, where the number rises week on week, is less common and tends to have a clearer cause. Keeping a simple weekly record (same time of day, same conditions) gives your prescriber usable data rather than a rough impression. The Wegovy overview at nume sets out the full titration pathway so you know what to expect at each stage.

If you are at maintenance dose and weight is still climbing, that is the signal to contact your prescriber, and it is worth reading about whether Wegovy can cause weight gain to understand what the evidence actually shows. NICE's appraisal of semaglutide for weight management (TA875) recommends reviewing whether to continue treatment if less than 5% body weight has been lost after six months on the maintenance dose.

Step 2, Identify whether doses have been delayed or missed

Semaglutide has a half-life of roughly one week, which is why once-weekly dosing works. But that also means consistency matters more than people sometimes realise. If injections slip from weekly to every ten or twelve days over several weeks, the steady-state concentration in your bloodstream falls, appetite suppression weakens, and caloric intake tends to creep back up before you notice it consciously.

A common pattern our prescribers see is someone who was doing well, had a busy few weeks, shifted their injection day a couple of times, and then found their hunger had noticeably returned. Picking a fixed day each week and anchoring it to something unmissable (keeping the pen in the fridge door next to something you reach for every Sunday morning, for example) is one of the most practical things patients mention. It is not a dosing instruction; just a memory prompt that many people find genuinely useful.

If you have missed doses and are unsure what to do, the nume FAQs cover the general guidance, and the Patient Information Leaflet that comes with your pen gives the manufacturer's instructions for missed injections. Your prescriber is the right person to ask if you are uncertain about your specific situation.

Step 3, Consider whether lifestyle factors have shifted

Wegovy reduces appetite, but it does not replace the lifestyle changes that support weight management. The NHS notes that weight-loss medicines work best alongside a reduced-calorie diet and increased physical activity. If those foundations shift (stress, illness, a change in work schedule, reduced sleep) the medicine's appetite effect may not fully compensate.

There is also a specific physiological response worth knowing about: as body weight falls, basal metabolic rate decreases. That means the caloric deficit that produced steady loss in the first few months may narrow over time even if your eating habits stay the same. This is not a flaw in the treatment; it is a normal biological adaptation, and our page on whether Wegovy can make you gain weight explains the mechanisms behind this in more detail. Prioritising protein and resistance activity during treatment helps preserve lean mass and partly offsets this. For broader context on how diet fits alongside treatment, the weight management overview covers the lifestyle component clearly.

If you are wondering whether the cost of continuing treatment is worthwhile given your progress, the Wegovy price comparison page explains what a complete, clinically supervised private prescription actually covers, sometimes helpful context when weighing up the options.

Step 4, Talk to your prescriber before stopping

The most reliably documented cause of significant weight gain on semaglutide is stopping the medicine. Evidence from the STEP 1 extension study, published in the New England Journal of Medicine, showed that participants who stopped semaglutide regained a substantial portion of the weight they had lost within a year, while those who continued maintained their results. The medicine does not reprogram metabolism permanently; it manages the biological drivers of appetite for as long as it is taken.

If you are considering stopping for any reason (cost, side effects, or a sense that it is no longer working) talking to a prescriber first is the right move. There may be a dose adjustment, a structured pause, or a switch worth discussing. The guide on stepping down from Wegovy covers what typically happens to weight when treatment ends, and what to expect after stopping sets out the evidence plainly. A prescriber who knows your history can help you plan rather than react. If you are ready to have that conversation, check your eligibility with our clinical team, there is no obligation, and the consultation is free.